Lv1
30 积分 2023-07-10 加入
Mitochondrial inhibitors circumvent adaptive resistance to venetoclax and cytarabine combination therapy in acute myeloid leukemia
1天前
已完结
3+7 Combined Chemotherapy for Acute Myeloid Leukemia: Is It Time to Say Goodbye?
1天前
已完结
Association of Measurable Residual Disease With Survival Outcomes in Patients With Acute Myeloid Leukemia
1天前
已完结
Inflammatory processes in the liver: divergent roles in homeostasis and pathology
1个月前
已完结
TP53‐Mutated Myeloid Neoplasms: 2024 Update on Diagnosis, Risk‐Stratification, and Management
2个月前
已完结
Novel Approaches to the Treatment of Chronic Graft-Versus-Host Disease
2个月前
已完结
Clinical insights into small cell lung cancer: Tumor heterogeneity, diagnosis, therapy, and future directions
5个月前
已完结
Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR-mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial
9个月前
已完结
First-Line Erlotinib Therapy Until and Beyond Response Evaluation Criteria in Solid Tumors Progression in Asian Patients With Epidermal Growth Factor Receptor Mutation–Positive Non–Small-Cell Lung Cancer
9个月前
已完结
Concurrent TP53 Mutations Facilitate Resistance Evolution in EGFR-Mutant Lung Adenocarcinoma
1年前
已完结
皖公网安备34019202002308
